Modified release preparations containing oxcarbazepine and derivatives thereof Grant US-11896599-B2 United States of America 13 Feb 2024
Methods of treatment of partial onset seizures using eslicarbazepine acetate Grant US-11364247-B2 United States of America 21 Jun 2022
Modified release preparations containing oxcarbazepine and derivatives thereof Grant US-11166960-B2 United States of America 09 Nov 2021
Methods of treatment of partial onset seizures using eslicarbazepine acetate Grant US-10702536-B2 United States of America 07 Jul 2020
Methods of treatment of partial onset seizures using eslicarbazepine acetate Grant US-10695354-B2 United States of America 30 Jun 2020
Methods of treatment of partial onset seizures using eslicarbazepine acetate Grant US-10675287-B2 United States of America 09 Jun 2020
Modified release preparations containing oxcarbazepine and derivatives thereof Application US-10220042-B2 United States of America 05 Mar 2019
Modified release preparations containing oxcarbazepine and derivatives thereof Application US-9855278-B2 United States of America 02 Jan 2018
Modified release preparations containing oxcarbazepine and derivatives thereof Application US-9370525-B2 United States of America 21 Jun 2016
Modified release preparations containing oxcarbazepine and derivatives thereof Application US-9351975-B2 United States of America 31 May 2016
Modified release preparations containing oxcarbazepine and derivatives thereof Application US-9119791-B2 United States of America 01 Sep 2015
Modified release preparations containing oxcarbazepine and derivatives thereof Application US-9119792-B2 United States of America 01 Sep 2015
Modified release preparations containing oxcarbazepine and derivatives thereof Application US-8821930-B2 United States of America 02 Sep 2014
Methods of treatment using a gastric retained gabapentin dosage form Grant US-8802157-B2 United States of America 12 Aug 2014
Gastric retentive gabapentin dosage forms and methods for using same Grant US-8592481-B2 United States of America 26 Nov 2013
Methods of treatment using a gastric retained gabapentin dosage Grant US-8529955-B2 United States of America 10 Sep 2013
Methods of treatment using a gastric retained gabapentin dosage Grant US-8475813-B2 United States of America 02 Jul 2013
Methods of treatment using a gastric retained gabapentin dosage Grant US-8440232-B2 United States of America 14 May 2013
OXCARBAZEPINE-CONTAINING ORAL FORMULATION AND A PROCESS TO OBTAIN THE SAME Application EP-2077822-A4 European Patent Office 15 Aug 2012
Extended release formulation of Levetiracetam Grant US-7863316-B2 United States of America 04 Jan 2011
Extended release formulation of levetiracetam Grant US-7858122-B2 United States of America 28 Dec 2010
OXCARBAZEPINE-CONTAINING ORAL FORMULATION AND A PROCESS TO OBTAIN THE SAME Application EP-2077822-A1 European Patent Office 15 Jul 2009
Methods for the treatment of bipolar disorder using carbamazepine Grant US-6977253-B2 United States of America 20 Dec 2005
Controlled release formulation of divalproex sodium Grant US-6720004-B2 United States of America 13 Apr 2004
Controlled release formulation of divalproex sodium Grant US-6713086-B2 United States of America 30 Mar 2004
Controlled release formulation of divalproex sodium Grant US-6528091-B1 United States of America 04 Mar 2003
Controlled release formulation of divalproex sodium Grant US-6528090-B2 United States of America 04 Mar 2003
Controlled release formulation of divalproex sodium Grant US-6511678-B2 United States of America 28 Jan 2003
Controlled release formulation of divalproex sodium Grant US-6419953-B1 United States of America 16 Jul 2002